Showing results (651-660 of 835) with videos related to

Sort By:
Pageof 84
Biorxiv : the Preprint Server for Biology|February 12, 2026
Components of an ESCRT-independent nuclear envelope assembly pathwayEmma M Sydir, M Humam Farra, Abigail L Whitford, et al.
The Clinical Journal of Pain|February 19, 2016
Multiple Levels of Suffering: Discrimination in Health-Care Settings is Associated With Enhanced Laboratory Pain Sensitivity in Sickle Cell DiseaseVani A Mathur, Kasey B Kiley, Carlton Haywood, et al.
The Journal of Infectious Diseases|September 23, 2021
The Impact of Real-Time Whole-Genome Sequencing in Controlling Healthcare-Associated SARS-CoV-2 OutbreaksRodric V Francis, Harriet Billam, Mitch Clarke, et al.
Pediatric Blood & Cancer|March 2, 2011
Initial testing (stage 1) of the polyamine analog PG11047 by the pediatric preclinical testing programMalcolm A Smith, John M Maris, Richard Lock, et al.
BMC Research Notes|April 24, 2014
Probable fatal drug interaction between intravenous fenretinide, ceftriaxone, and acetaminophen: a case report from a New Approaches to Neuroblastoma (NANT) Phase I studyMin H Kang, Judith G Villablanca, Julia L Glade Bender, et al.
Pediatric Blood & Cancer|February 9, 2008
Initial testing (stage 1) of a monoclonal antibody (SCH 717454) against the IGF-1 receptor by the pediatric preclinical testing programE Anders Kolb, Richard Gorlick, Peter J Houghton, et al.
Psychopharmacology|October 29, 2021
Selenium abates manganese-induced striatal and hippocampal toxicity via abrogation of neurobehavioral deficits, biometal accumulation, oxidative stress, inflammation, and caspase-3 activation in ratsKpobari W Nkpaa, Bright B Nkpaa, Benjamin A Amadi, et al.
Pediatric Blood & Cancer|June 8, 2007
Initial testing of cisplatin by the pediatric preclinical testing programMimi Tajbakhsh, Peter J Houghton, Christopher L Morton, et al.
Antiviral Research|January 8, 2017
Tracking HCV protease population diversity during transmission and susceptibility of founder populations to antiviral therapyTanvi Khera, Daniel Todt, Koen Vercauteren, et al.
Pediatric Blood & Cancer|August 19, 2014
Initial solid tumor testing (stage 1) of AZD1480, an inhibitor of Janus kinases 1 and 2 by the pediatric preclinical testing programPeter J Houghton, Raushan T Kurmasheva, Dmitry Lyalin, et al.
Pageof 84